Views | |
---|---|
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 145 |
December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
---|---|---|---|---|---|---|---|
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 1 | 2 | 1 | 4 | 8 | 6 | 2 |
Views | |
---|---|
2021_Correll_etal.pdf | 40 |